#TALK Research - Middlemore Clinical Trials Newsletter
21/12/2022
We would like to share with you our plans to change the name of Middlemore Clinical Trials.
Read moreLatest News
Study reveals recommended anticoagulant therapy for COVID patients
13/12/2022
The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalised with COVID-19, in a study published in the New England Journal of Medicine Evidence and presented at the American Society for Hematology conference today.
Read more
Middlemore Clinical Trials Annual Report FY22
19/10/2022
in bringing novel clinical trials to the community of Counties Manukau.
Read more
August #TALK.Research Newsletter CMH_PI_HoD
10/08/2022
than ever before and enrolled more participants than any preceding year.
Read more
Kiwi women taking part in global trial of RSV vaccine
04/05/2022
RSV causes lung and respiratory tract infections and is highly contagious, there is no effective vaccine or cure for it. The virus is usually not serious for adults and older children but infants and premature babies can become very sick. Pfizer is carrying out the vaccine trial, which is currently in phase three and is given to pregnant women rather than the baby.
Read more
#TALK Research - Middlemore Clinical Trials Newsletter
08/03/2022
The requests for Middlemore Clinical Trials to be involved in clinical trials has never been greater.
Read more
Spotlight on the Renal Department
02/03/2022
March is Kidney Health month, which is an opportunity to highlight the great work the Renal department does for the Counties Manukau catchment.
Read more
#TALK Research - Middlemore Clinical Trials Newsletter
13/12/2021
Haematology is the focus for this newsletter as we acknowledge the exciting and ground breaking efforts of the Middlemore Hospital haematology department in making clinical trials available to their patients.
Read more